chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain, Pain in extremity, Somnolence
Clinical narrative: I'm sorry I don't know the specific vaccine, but it was the flu vaccine for the 2017/2018 flu season. I had the standard ache and drowsiness for 2 days following the shot. But 1 week and 2 days later, the arm pain has changed and worsened. I now have on and off muscle pain at the site of the injection. I can move my arm without issue, and I haven't been able to identify the trigger for the pain to start/stop. The pain is mild to moderate (up to a 4 out of 10 on the pain scale) and the pain seems to increase when I use my fingers for anything dexterous, like typing. At this point, I have not been able to identify anything to alleviate the pain.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site pain, Injection site swelling, Malaise, Rash erythematous
Clinical narrative: Patient has malaise and general fatigue for 48 hours after dose. Patient also had significant swelling at the injection site and red-patchy rash that lasted 5 days. Patient experienced significant soreness at injection site that also lasted about 5 days.
Age: 61.0
Sex: F
Vaccine: FLU4
Symptoms: Nausea, Pain in extremity
Clinical narrative: Patient states the day after she experienced nausea and pain in the legs.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Bedridden, Diarrhoea, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: SWELLING, HARD AND SORE AT INJECTION SITE. DIARRHEA, VOMITING, SEVERE WHOLE BODY MUSCLE PAIN. WAS BEDRIDDEN FOR 4 DAYS AND TOOK A TOTAL OF 10 DAYS TO RECOVER. PATIENT STATED THE ADVERSE EVENTS STARTED WITHIN 1/2 TO 1 HOUR AFTER THE VACCINE. TOOK ALEVE FOR THE MUSCLE PAIN AND DID NOT SEEK MEDICAL HELP.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Myalgia, Vomiting
Clinical narrative: SWELLING, HARD AND SORE AT INJECTION SITE. DIARRHEA, VOMITING, SEVERE WHOLE BODY MUSCLE PAIN. WAS BEDRIDDEN FOR 4 DAYS AND TOOK A TOTAL OF 10 DAYS TO RECOVER. PATIENT STATED THE ADVERSE EVENTS STARTED WITHIN 1/2 TO 1 HOUR AFTER THE VACCINE. TOOK ALEVE FOR THE MUSCLE PAIN AND DID NOT SEEK MEDICAL HELP.
Age: 48.0
Sex: F
Vaccine: DTAP
Symptoms: Electromyogram, Injection site erythema, Injection site nodule, Injection site pain, Injection site warmth
Clinical narrative: Knot and redness at injection sight with severe pain in arm. Warmer at injection sight than other parts of arm. Initial clinic dr told me to take ibuprofen for 5 to 7 days. It was no better. Was then prescribed malaxocam. No help. Was told it would get better with time. Symptoms continued and have lasted over 9 months. Have had tingle( pins and needles) type feeling down to my fingers for over 9 months now.  Knot at injection sight and warmth went away at 7 months but still tender in that spot. Was sent to neurologist by another doctor and had EMG. Then sent to ortho doctor. Now undergoing occupational therapy.
Age: 48.0
Sex: F
Vaccine: DTAP
Symptoms: Pain in extremity, Paraesthesia, X-ray
Clinical narrative: Knot and redness at injection sight with severe pain in arm. Warmer at injection sight than other parts of arm. Initial clinic dr told me to take ibuprofen for 5 to 7 days. It was no better. Was then prescribed malaxocam. No help. Was told it would get better with time. Symptoms continued and have lasted over 9 months. Have had tingle( pins and needles) type feeling down to my fingers for over 9 months now.  Knot at injection sight and warmth went away at 7 months but still tender in that spot. Was sent to neurologist by another doctor and had EMG. Then sent to ortho doctor. Now undergoing occupational therapy.
Age: 1.25
Sex: M
Vaccine: FLU4, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Irritability, Poor quality sleep, Pyrexia, Rash, Rash macular
Clinical narrative: Low grade fever for 3 days. On day three, red blotchy rash on trunk of body. Poor sleeping and general fussiness for duration.
Age: 63.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pain
Clinical narrative: In approximately 18 hours following the flu vaccine, my left arm ached at the site of the injection. It has now been two months since the injection, and my arm at the site of the injection still aches several times each day. I am a true believer in vaccines and have always had a flu shot. This is the first time I had the senior dose.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Mobility decreased, Musculoskeletal pain, Neck pain, Pain
Clinical narrative: Was administered a flu shot at my workplace by a pharmacy employee. Two days later my left arm began to hurt. On the third day the pain extended to the shoulder and the left side of neck. I lost strength in arm and was unable to lift heavy objects as well as lift arm. Tried to alleviate the pain with ICYHOT patches but they did not work. I then visited my physician and was prescribed BEVODINIX 1 capsule every 12 hours. To date the pain has not gone away. Can lift arm and strength is back but arm still in pain when I try to lift it and cannot lift past shoulder without pain.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: Was administered a flu shot at my workplace by a pharmacy employee. Two days later my left arm began to hurt. On the third day the pain extended to the shoulder and the left side of neck. I lost strength in arm and was unable to lift heavy objects as well as lift arm. Tried to alleviate the pain with ICYHOT patches but they did not work. I then visited my physician and was prescribed BEVODINIX 1 capsule every 12 hours. To date the pain has not gone away. Can lift arm and strength is back but arm still in pain when I try to lift it and cannot lift past shoulder without pain.
Age: 44.0
Sex: F
Vaccine: FLUC4
Symptoms: Electromyogram, Muscular weakness, Nerve injury, Neuralgic amyotrophy, Nuclear magnetic resonance imaging
Clinical narrative: Severe and excruciating pain in left arm and shoulder weakness and nerve damage and pain in left arm. Diagnosed with Parsonage Turner's Syndrome due to flu shot received on 9/27/17.
Age: 44.0
Sex: F
Vaccine: FLUC4
Symptoms: Pain in extremity, Ultrasound Doppler, X-ray
Clinical narrative: Severe and excruciating pain in left arm and shoulder weakness and nerve damage and pain in left arm. Diagnosed with Parsonage Turner's Syndrome due to flu shot received on 9/27/17.
Age: 34.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Loss of consciousness, Muscle tightness, Posture abnormal
Clinical narrative: He lost consciousness after the second vaccine (FLUVIRIN) I gave in the right Deltoid. For about 5 seconds while sitting in the chair. I felt his body tightening and falling forward. He did not fall but was going to slump over. Called 911 and vitals were taken. His vitals were ok and they left. He got a ride from his girlfriend.
Age: 75.0
Sex: F
Vaccine: PNC13
Symptoms: Cyanosis, Injection site nodule, Injection site reaction
Clinical narrative: Pt stated injection site and area around turned blue and a big knot formed where injection was given.
Age: 2.0
Sex: F
Vaccine: DTAP
Symptoms: Skin discolouration, Tremor, Vomiting projectile
Clinical narrative: Severe projectile vomiting, shaking and hands and feet turning purple. Took her to the ER, they administered Zofran and told us to ride it out basically.
Age: 34.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injection site erythema, Injection site swelling, Vaccination site induration, Vaccination site nodule
Clinical narrative: Severe swelling (site greater than silver dollar, visibly raised from skin), redness, hard knot at vaccination site.
Age: 34.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injection site erythema, Vaccination site induration, Vaccination site nodule, Vaccination site swelling
Clinical narrative: Severe swelling (site greater than silver dollar, visibly raised from skin), redness, hard knot at vaccination site.
Age: 2.0
Sex: M
Vaccine: FLU4, VARCEL
Symptoms: Blister, Injection site rash, Injection site vesicles, Rash
Clinical narrative: About two weeks after the vaccination a small rash appeared on patient's leg, around the site of injection. These small blisters resolved on their own in about 3-4 days and never seemed to cause him any discomfort. Then, on December 20th, a larger, more widespread rash appeared over the left side of his chest, arm, armpit, neck, and cheek. This round of blisters/pox seemed to bother him more but also resolved on their own in about 4 or 5 days. I have photos available if they would prove useful.
Age: 69.0
Sex: M
Vaccine: PPV
Symptoms: Injection site swelling, Peripheral swelling
Clinical narrative: Two days following administrations of PNEUMOVAX 23 vaccine, patient presented to ER with significant left arm swelling, at the site where vaccine was administered. He experienced no pain, only extreme swelling of his left arm.
Age: 0.17
Sex: F
Vaccine: DTAP, HEP, HIBV, RV5
Symptoms: Constipation
Clinical narrative: Chronic constipation.
Age: 55.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Beginning day after vaccine, patient had redness at injection site, warm painful sensations, surrounding skin felt swollen/hard to the touch. Patient did not self-treat symptoms and symptoms were persistent until day of report.
Age: 67.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Infection, Pyrexia, Rash
Clinical narrative: Patient called pharmacy on 1/13/18 and complained of a rash after receiving 2 immunizations in the same arm on 1/10/18. He explained that the rash began on 1/11/18 in the morning and fever began in the evening  of 1/11/18. He stated he took MOTRIN for the fever and currently didn't have a fever on 1/13/18 but he had taken some MOTRIN that day. On 1/13/18 the pharmacist discussed possible adverse reactions to both immunizations and advised him how to take BENADRYL, use an ice pack, take TYLENOL, and to seek urgent care if condition worsened. On 1/13/18 he went to urgent care and they told him he had an infection. He stated that they placed him on antibiotics (generic BACTRIM DS).
Age: 4.0
Sex: F
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Eye swelling, Lip swelling, Rash generalised, Rash macular, Rash pruritic
Clinical narrative: Within 24 hours patient has a severe rash all over her skin. From her face to her feet. Very blotchy, red, and itchy. She also had swollen lips and eyes. We visited the ER and she received an oral steroid.
Age: 55.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Cellulitis, Chills, Cyst removal, Injection site cellulitis, Injection site cyst
Clinical narrative: Right upper arm became red/swollen about 6x6 wide. I had fevers & chills. Right arm was hot to the touch. I went to the ER on 12/12/16 at the same facility where I received the shot. Diagnosis was cellulitis in the right shoulder where I received pneumonia shot. I was given antibiotics. From 12/8/16 to 9/2017 - I developed multiple recurring cellulitis infections in my right arm. I kept going back to the same facility where I was told it was scar tissue. In Sept 2017, I went to a different Dr who put me back on 2 types of antibiotics for a month and I was referred to an infectious disease Dr. The infectious disease Dr ordered an MRI which indicated a foreign object in my arm. I was referred to a surgeon and had surgery in December 2017 to remove the foreign object which turned out to be a cyst that had developed from the pneumonia shot.
Age: 55.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site swelling, Nuclear magnetic resonance imaging abnormal, Pyrexia, Skin warm
Clinical narrative: Right upper arm became red/swollen about 6x6 wide. I had fevers & chills. Right arm was hot to the touch. I went to the ER on 12/12/16 at the same facility where I received the shot. Diagnosis was cellulitis in the right shoulder where I received pneumonia shot. I was given antibiotics. From 12/8/16 to 9/2017 - I developed multiple recurring cellulitis infections in my right arm. I kept going back to the same facility where I was told it was scar tissue. In Sept 2017, I went to a different Dr who put me back on 2 types of antibiotics for a month and I was referred to an infectious disease Dr. The infectious disease Dr ordered an MRI which indicated a foreign object in my arm. I was referred to a surgeon and had surgery in December 2017 to remove the foreign object which turned out to be a cyst that had developed from the pneumonia shot.
Age: 33.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Influenza like illness, Injection site erythema, Injection site pain, Injection site warmth, Nausea
Clinical narrative: Pain at both injection sites, but greater on left side (PPSV23) than right (Tdap) for 3 days. Hot, red area approximately 3 inches long and 2 inches wide close to PPSV23 injection site (area of injection and distal from it), painful to touch for two and a half days. Nausea, low grade fever (100F), and other flu-like symptoms for approximately 24 hours.
Age: 33.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Pyrexia
Clinical narrative: Pain at both injection sites, but greater on left side (PPSV23) than right (Tdap) for 3 days. Hot, red area approximately 3 inches long and 2 inches wide close to PPSV23 injection site (area of injection and distal from it), painful to touch for two and a half days. Nausea, low grade fever (100F), and other flu-like symptoms for approximately 24 hours.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Back pain, Dizziness, Erythema, Fatigue, Feeling of body temperature change
Clinical narrative: 12-15: Headache, lower back pain, nausea, swelling of right arm. 12-16: Headache, back pain, nausea, dizziness, hot/cold body symptoms, exhaustion. Approx. 6-8 size redness of injection site. Started TYLENOL and BENADRYL per Dr. orders. 12-17: still continue on TYLENOL and BENADRYL. Developed rash on face-all over-red, also rash over redness on arm of injection site. Included all of the following wk. until Dec 21, 17. I felt tired and arm took all this week at least to get the inflammation out. The sickest week I have felt in a lot of years and I am 65.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Headache, Injection site erythema, Nausea, Peripheral swelling, Rash
Clinical narrative: 12-15: Headache, lower back pain, nausea, swelling of right arm. 12-16: Headache, back pain, nausea, dizziness, hot/cold body symptoms, exhaustion. Approx. 6-8 size redness of injection site. Started TYLENOL and BENADRYL per Dr. orders. 12-17: still continue on TYLENOL and BENADRYL. Developed rash on face-all over-red, also rash over redness on arm of injection site. Included all of the following wk. until Dec 21, 17. I felt tired and arm took all this week at least to get the inflammation out. The sickest week I have felt in a lot of years and I am 65.
Age: 68.0
Sex: M
Vaccine: PPV, VARCEL
Symptoms: Injection site pain, Spinal X-ray, Ultrasound scan, X-ray limb
Clinical narrative: Patient with increasing pain/burning at the injection site and right arm after Zoster vaccine. Pain still occurring about 3 months after injection. MD visit for further work-up with CT and MRI in December. Also given gabapentin for pain in right arm.
Age: 1.0
Sex: M
Vaccine: DTP, FLUX, IPV, PPV
Symptoms: Abnormal behaviour, Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2016US163824, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 648448) on 21 Nov 2016. This report refers to a 01 year and 03 months old male patient. Past medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine Inn (manufacturer, batch number: not reported), Poliovirus Vaccine Inactivated (other manufacturer, batch number: not reported) and pneumococcal vaccine (other manufacturer, batch number: not reported) on 11 Feb 2016). On the same day in the evening after vaccination, the patient's right leg red, swollen, tight, warm to the touch, had fever and was not himself, these events lasted two whole days. The outcome of the events was reported as complete recovery. The seriousness and causality of the events was not reported.
Age: 1.0
Sex: M
Vaccine: DTP, FLUX, IPV, PPV
Symptoms: Pyrexia, Skin tightness
Clinical narrative: Case number PHHY2016US163824, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 648448) on 21 Nov 2016. This report refers to a 01 year and 03 months old male patient. Past medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine Inn (manufacturer, batch number: not reported), Poliovirus Vaccine Inactivated (other manufacturer, batch number: not reported) and pneumococcal vaccine (other manufacturer, batch number: not reported) on 11 Feb 2016). On the same day in the evening after vaccination, the patient's right leg red, swollen, tight, warm to the touch, had fever and was not himself, these events lasted two whole days. The outcome of the events was reported as complete recovery. The seriousness and causality of the events was not reported.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Anxiety, Arthritis, Asthenia, Dizziness, Dysphonia
Clinical narrative: Case number PHHY2016US164610, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 651120) website on 21 Nov 2016. This report refers to a 65 years old female patient. Prior vaccination history included as, patient vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) on an unknown date with unspecified side effects (reported as, not as bad as this year). Past medical history was not reported. Current condition included as sprained ankle, allergy penicillin aspirin latex tetracycline and allergy medication. Concomitant medications included as lorazepam, bupropion, bromide, PERIDOX, FRESH TEARS, Vitamin C, Vitamin D, VITAFIBER, Probiotic and Lactate pills. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 05 Aug 2016. On the same day after vaccination (By afternoon), the patient experienced hoarseness, itchy eyes, headache, fatigue, weakness, dizziness, fast heartbeat, warts, panic attacks. Weeks later patient still had itchy eyes, anxiety, weakness, dizziness, rapid heartbeats and trouble focusing. Patient called physician but did not go to the office and told to take lots of liquids and go to emergency room if worsen. Lately patient had also blurry eyes, pain in eyes for a while, noise/pain in ears, arthritis has been worse since vaccination on an unknown date. There was swelling in the area in the beginning on an unspecified date. The outcome of the events was reported as condition unchanged. The seriousness of the events was not reported. The causality of the events was not reported.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Ear pain, Eye pain, Eye pruritus, Fatigue, Headache
Clinical narrative: Case number PHHY2016US164610, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 651120) website on 21 Nov 2016. This report refers to a 65 years old female patient. Prior vaccination history included as, patient vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) on an unknown date with unspecified side effects (reported as, not as bad as this year). Past medical history was not reported. Current condition included as sprained ankle, allergy penicillin aspirin latex tetracycline and allergy medication. Concomitant medications included as lorazepam, bupropion, bromide, PERIDOX, FRESH TEARS, Vitamin C, Vitamin D, VITAFIBER, Probiotic and Lactate pills. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 05 Aug 2016. On the same day after vaccination (By afternoon), the patient experienced hoarseness, itchy eyes, headache, fatigue, weakness, dizziness, fast heartbeat, warts, panic attacks. Weeks later patient still had itchy eyes, anxiety, weakness, dizziness, rapid heartbeats and trouble focusing. Patient called physician but did not go to the office and told to take lots of liquids and go to emergency room if worsen. Lately patient had also blurry eyes, pain in eyes for a while, noise/pain in ears, arthritis has been worse since vaccination on an unknown date. There was swelling in the area in the beginning on an unspecified date. The outcome of the events was reported as condition unchanged. The seriousness of the events was not reported. The causality of the events was not reported.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Heart rate increased, Panic attack, Skin papilloma, Tinnitus, Vision blurred
Clinical narrative: Case number PHHY2016US164610, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 651120) website on 21 Nov 2016. This report refers to a 65 years old female patient. Prior vaccination history included as, patient vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) on an unknown date with unspecified side effects (reported as, not as bad as this year). Past medical history was not reported. Current condition included as sprained ankle, allergy penicillin aspirin latex tetracycline and allergy medication. Concomitant medications included as lorazepam, bupropion, bromide, PERIDOX, FRESH TEARS, Vitamin C, Vitamin D, VITAFIBER, Probiotic and Lactate pills. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 05 Aug 2016. On the same day after vaccination (By afternoon), the patient experienced hoarseness, itchy eyes, headache, fatigue, weakness, dizziness, fast heartbeat, warts, panic attacks. Weeks later patient still had itchy eyes, anxiety, weakness, dizziness, rapid heartbeats and trouble focusing. Patient called physician but did not go to the office and told to take lots of liquids and go to emergency room if worsen. Lately patient had also blurry eyes, pain in eyes for a while, noise/pain in ears, arthritis has been worse since vaccination on an unknown date. There was swelling in the area in the beginning on an unspecified date. The outcome of the events was reported as condition unchanged. The seriousness of the events was not reported. The causality of the events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Back pain, Musculoskeletal pain
Clinical narrative: Case number PHHY2016US164526, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 655036) on 21 Nov 2016. This report refers to a 69 years old female patient. Past medical history was not reported. Current conditions included allergies to dust, weeds and to dust mites. Concomitant medication included atorvastatin, cetirizine, fesoterodine, hydrochlorothiazide, levothyroxine, omeprazole. The patient was vaccinated with INN (manufacturer unknown, batch number: not reported) on 19 Sep 2016 in to the right arm. On same day after vaccination, the patient's shoulders and back hurt like she had been hit with a hammer, for about 36 hours. Treatment medication included ALEVE, which did not help the patient. The outcome of the events was reported as complete recovery. Seriousness and causality of the events was not reported.
Age: 52.0
Sex: M
Vaccine: FLUX, VARZOS
Symptoms: Chills, Local reaction, Pyrexia
Clinical narrative: Case number PHHY2017US019644, is an initial spontaneous report received from a medical assistant via Vaccine Adverse Events Reporting System (VAERS reference number: 656043) on 23 Jan 2017. This report refers to a 52 years old male patient. Historical condition was not reported. Current condition included drug allergies to ibuprofen and aspirin. Concomitant medication included Fenofibrate, lisinopril, COZAAR, lycopene, Multivitamin, propranolol hydrochloride, ZOCOR, Vitamin C, Vitamin D and ZYRTEC. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) and ZOSTAVAX subcutaneously at a dose of 0.5 ml (half CC, incorrect dose administered), both on different arm on 31 Aug 2016. On an unknown date in 2016 after vaccination, the patient developed general and local reactions (not specified), fever and chills. The patient received unspecified treatment. There was no laboratory tests performed. The patient went to emergency room on an unknown date. The outcome of the events was reported as currently recovering (condition improving). The seriousness of the events was reported as non serious and causality was not reported.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Facial pain, Neuralgia, Pain, Toothache, X-ray dental normal
Clinical narrative: Case number PHHY2016US164297 is an initial spontaneous report received from a consumer via the Vaccine Adverse Event Reporting System (VAERS reference number: 657124) on 21 Nov 2016. This report refers to 52 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown) intramuscular into left arm on 30 Sep 2016. On 01 Oct 2016, the patient experienced severe left nerve/facial pain also sharp pain only on left side upper and lower teeth, felt like shocking pain, throbbing and unbearable throughout the whole day. The patient had easing up now on day 4. On 02 Oct 2016, the patient visited emergency dental visit and undergone for dental X-ray rule out abscess or any tooth related episode. 02 Oct 2016 patient saw physician got labs and CT scan ordered and PERCOCET and Flexeril prescribed for pain. The outcome of the events was reported as condition improving. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: M
Vaccine: FLUX, HEPA
Symptoms: Blood test abnormal, Synovitis, Ultrasound scan abnormal, X-ray of pelvis and hip abnormal
Clinical narrative: Case number PHHY2016US163973, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (V02 AERS reference number: 657996) website on 21 Nov 2016. This report refers to a 02 years old male patient. Past medical history included as ventricular septal defect (VSD) at birth-has closed. Concomitant medications was not reported. The patient was vaccinated with INN (manufacturer and batch number: not reported) on 22 Sep 2016 when he was 02 years old. The patient also vaccinated with hepatitis A vaccine (other manufacture, batch number: not reported) on 22 Sep 2016. The patient was performed blood work and x rays, ultrasound scan and confirmed diagnosis of transient synovitis of the hip on 04 Oct 2016. The patient visited the emergency room. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Nausea
Clinical narrative: Case number PHHY2016US167430, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658514) on 21 Nov 2016. This report refers to a 55 years old female patient. Medical history and current condition was reported as none. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619401) intramuscularly into left arm on 22 Sep 2016. On same day after vaccination, the patient felt queasy and lightheaded. The patient was taken to the emergency room. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: FLU3
Symptoms: Musculoskeletal pain, Pain in extremity
Clinical narrative: Case number PHHY2017US019729, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 663029) website on 23 Jan 2017. This report refers to a 36 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 169221) into left arm, intramuscularly on 04 Oct 2016. On 11 Oct 2016, the patient experienced soreness in the back of her arm and shoulder, appearing one week after flu vaccine. It was relieved when taking ibuprofen. Patient advised to seek medical evaluation. The patient visited the emergency room. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 65.0
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Acupuncture, Injected limb mobility decreased, Musculoskeletal stiffness
Clinical narrative: Case number PHHY2017US018372, is an initial spontaneous report received from a consumer (patient) via Vaccine Adverse Event Reporting System (VAERS reference number: 664831) website on 23 Jan 2017. This report refers to a 65 years old female patient. Past medical history was not reported. Current condition included as blood pressure abnormal, muscle relaxant and pain. Concomitant medications included as hydrochlorothiazide for blood pressure abnormal, hydrocodone for pain and tizanidine for muscle relaxant. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 06 Sep 2016. The patient also vaccinated with single dose of PREVNAR 13 vaccine (other manufacture and batch number: not reported) into right arm on 06 Sep 2016. On the same day after vaccination, the patient experienced right arm messed up and her arm started to get stiff, not able to raise her arm to do anything with her right arm anymore. The patient was treated with acupuncture. The outcome of the events was reported as unknown. The seriousness and causality of the events were not reported.
Sex: M
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: This spontaneous case, initially received on 12-Jan-2017, was reported by a health authority and concerns a male patient. Weight: not provided; Height: not provided. Concomitant medication: not reported. Administration of company suspect drug(s): On an unknown date, the patient received Influenza Virus Vaccine (INN). Dose regimen: Not reported, Route of administration: Not Reported. Batch number: Not reported. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced a rash (outcome: not reported). Linked Case ID(s): US-BEH-2017077492 (same patient). 14-MAR-2017 (System update): Linked Case ID(s): 2017077492 (Patient Link).
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Nausea
Clinical narrative: Case number PHHY2017US019057, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 664891) website on 23 Jan 2017. This report refers to a 39 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1620001) into left arm (left deltoid), intramuscularly on 25 Oct 2016. On an unspecified date, the patient injection site was warm to touch, burning sensation, painful and had a raised red area where vaccine was given the size of a 50 cent piece per patient. Patient came to clinic on 26 Oct 2016 and informed us of this. Patient said she felt a little nauseated on an unknown date. On 27 Oct 2016, patient was much better the site not as red or warm and was down to 25 cent size. Patient used cool compresses. The outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the events were not reported.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Pain
Clinical narrative: Case number PHHY2017US018505 is an initial spontaneous report received from other healthcare professional via Vaccine Adverse Event Reporting System (VAERS number: 666637) website on 23 Jan 2017. This report refers to 19 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 169005) intramuscular into right arm on 13 Oct 2016. On 22 Oct 2016 the patient had continue with discomfort, no redness, no swelling, full right arm. On 25 Oct 2016 patient had continued with pain. The patient received non steroidal anti-inflammatory drugs (NSAID, details not reported). On 01 Nov 2016 patient with some improvement continue NSAID and right arm (ROM), patient visited emergency room (date not reported). The outcome of the events was reported as complete recovery on an unspecified date. The seriousness of the events was non serious, causality of the events was not reported.
Age: 64.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Hypoaesthesia, Induration, Injection site bruising, Injection site pain, Limb mass
Clinical narrative: Case number PHHY2017US017407 is an initial spontaneous report received from other healthcare professional via Vaccine Adverse Event Reporting System (VAERS number: 671408) website on 23 Jan 2017. This report refers to 64 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1620201) intramuscular into left arm and PREVNAR 13 (other manufacturer, batch number: N97936) on 16 Nov 2016. On the same day, shot hurt going in and that she had been having pain that would wake her up at night since having the shots. She also had a moderately hard lump on the inside of her elbow and a healing bruise at the injection site. On 09 Dec 2016, patient came in with complaint of numbness, tingling in arm. Nurse reported the symptoms. Patient told to follow up with her doctor about pain/numbness and to check golf ball size lump. The patient visited emergency room/doctor (date not reported). The outcome of the events was condition unchanged. seriousness of the events was non serious and causality of the events was not reported.
Age: 64.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Pain, Paraesthesia, Sleep disorder
Clinical narrative: Case number PHHY2017US017407 is an initial spontaneous report received from other healthcare professional via Vaccine Adverse Event Reporting System (VAERS number: 671408) website on 23 Jan 2017. This report refers to 64 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1620201) intramuscular into left arm and PREVNAR 13 (other manufacturer, batch number: N97936) on 16 Nov 2016. On the same day, shot hurt going in and that she had been having pain that would wake her up at night since having the shots. She also had a moderately hard lump on the inside of her elbow and a healing bruise at the injection site. On 09 Dec 2016, patient came in with complaint of numbness, tingling in arm. Nurse reported the symptoms. Patient told to follow up with her doctor about pain/numbness and to check golf ball size lump. The patient visited emergency room/doctor (date not reported). The outcome of the events was condition unchanged. seriousness of the events was non serious and causality of the events was not reported.
Age: 16.0
Sex: F
Vaccine: HPV9
Symptoms: Facial asymmetry, Interchange of vaccine products
Clinical narrative: This spontaneous report as received from a nurse, referring to a 16 year old female patient with menstrual disorder. The patient did not have any known allergies, reactions or concomitant medications. On 18-FEB-2015, the patient was vaccinated with an unknown dose of GARDASIL, intramuscular, lot /batch reported as: K008233 (expiration date was not reported) for prophylaxis reported as prevention of HPV. On 11-DEC-2017, the patient received an unknown dose of GARDASIL 9 intramuscular, lot # N023952, expiration date 12-JUL-2020 for prophylaxis reported as prevention of HPV. On 13-DEC-17, the patient reported to her teacher that she "noticed asymmetry (Facial asymmetry) with her smile while taking a selfie".  It was also mentioned that pertinent laboratories were not performed and the patient did no received treatment for the adverse event. The outcome of facial asymmetry was reported as not recovered. The causal relationship between GARDASIL and the events was not reported. The causal relationship between GARDASIL 9 and the events was not reported. The lot number K008233 is an invalid lot number for GARDASIL.
Sex: M
Vaccine: MMR
Symptoms: Injection site reaction, Skin mass
Clinical narrative: This spontaneous report as received from a physician refers to a 15 month old male patient. On an unknown date, the patient was vaccinated with a 0.5 ml "twice" dose of M-M-R II (dose and lot # not reported) subcutaneously. On an unknown date, the patient experienced a subcutaneous nodule at the injection site. At the time of the report, the patient's ouctome was unknown.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 17-NOV-2017, the patient was vaccinated with an improperly stored dose of PROQUAD lot # N016994, expiration date 29-NOV-2018, for prophylaxis (strength, dose, route and frequency were not reported). The PROQUAD was reconstituted with a properly stored sterile diluent (MERCK) lot # M034763, expiration date 22-APR-2019. The temperature excursion was of 6°F to 14°F, during 120 hours 30 minutes. However, a previous temperature excursion of 47°F to 50°F for 35 minutes was also reported. A digital data logger was involved. No adverse effects were reported. Additional information is not expected. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1801USA003525: US-009507513-1801USA003527: US-009507513-1801USA003526: US-009507513-1801USA003524: US-009507513-1801USA003523: US-009507513-1801USA003522: US-009507513-1801USA003521: US-009507513-1801USA003520: US-009507513-1801USA003612.
Age: 76.0
Sex: U
Vaccine: PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a consumer via Clinic refers to a currently 77 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 16-JUN-2017, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 1 dose unit (lot # M036728, Expiry date was not reported) for prophylaxis. There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1801USA000346: US-009507513-1801USA000349: US-009507513-1801USA000342: US-009507513-1801USA000344: US-009507513-1801USA000347: US-009507513-1801USA000345: US-009507513-1801USA000339: US-009507513-1801USA000340: US-009507513-1801USA000341: US-009507513-1801USA000343: US-009507513-1801USA000348: US-009507513-1801USA000338: US-009507513-1801USA000363: US-009507513-1801USA000361: US-009507513-1801USA000367: US-009507513-1801USA000359: US-009507513-1801USA000355: US-009507513-1801USA000371: US-009507513-1801USA000356: US-009507513-1801USA000357: US-009507513-1801USA000358: US-009507513-1801USA000369: US-009507513-1801USA000370: US-009507513-1801USA000368: US-009507513-1801USA000373: US-009507513-1801USA000374: US-009507513-1801USA000375: US-009507513-1801USA000376: US-009507513-1801USA000377: US-009507513-1801USA000378: US-009507513-1801USA000379: US-009507513-1801USA000380: US-009507513-1801USA000381: US-009507513-1801USA000382: US-009507513-1801USA000383: US-009507513-1801USA000384: US-009507513-1801USA000352: US-009507513-1801USA000354: US-009507513-1801USA000360: US-009507513-1801USA000364: US-009507513-1801USA000366: US-009507513-1801USA000372: US-009507513-1801USA000385: US-009507513-1801USA000387: US-009507513-1801USA000386: US-009507513-1801USA000388: US-009507513-1801USA000350: US-009507513-1801USA000351: US-009507513-1801USA000353: US-009507513-1801USA000362: US-009507513-1801USA000365.
Sex: F
Vaccine: PPV
Symptoms: Back pain, Dizziness, Erythema, Flushing
Clinical narrative: This spontaneous report was received from a pharmacist referring to a female patient of unknown age. The patient did not have any pertinent medical history, concurrent conditions, drug reaction/allergy neither was taken any concomitant medication. On 28-DEC-2017, at pharmacy, the patient was vaccinated with PNEUMOVAX23, intramuscularly, lot # N023651, expiration date on 20-MAY-2019, for pneumonia (strength and dose were not reported). On 28-DEC-2017 (also reported as 28-DEC-2019), the patient experienced facial flushing, lower back pain, erythema on both hands and complained of feeling faint. The patient sought medical attention; thus, the paramedics were called to the scene and the patient's vitals were taken. Then, she said that she felt fine. The episode lasted for 15 minutes and the pharmacist instructed the patient to take TYLENOL and to apply a heating pad to her lower back. Finally, no laboratory studies were performed. On 29-DEC-2017, at morning, the patient called the pharmacist and said that all her symptoms have resolved at an unspecified time after TYLENOL and heating pad were used. The causality assessment between the events and vaccination with PNEUMOVAX23 was not provided.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: Information has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions/allergies or medical history. The patient's concomitant medication included sterile diluent. On 28-DEC-2017, the patient received an improperly stored dose of PROQUAD for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse effect reported. It was reported that on an unspecified date, the vaccine was exposed to a temperature between -9° Celsius degrees and 8 Celsius degrees for 2 hours and 40 minutes. There was no previous temperature excursion. The call was placed because of a Digital Data logger report.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Hypersensitivity, Injection site swelling
Clinical narrative: This spontaneous report was received from an approximately 68 year old female patient, reporting on herself. The patient was taking at the moment of this report several unspecified concomitant medications. There were no pertinent medical history, drug reactions or allergies. On an unspecified date in 2008, the patient was vaccinated with a dose of PNEUMOVAX 23 Injection, for prophylaxis (reported as "to prevent pneumonia")(strength, dose, dose number, route, anatomical location, lot # and expiration date not reported). On an unspecified date in 2008, after the patient was vaccinated with PNEUMOVAX 23, she experienced swelling at the injection site, which she described as "a little bit of an allergic reaction". She did not receive any treatment for this event, and she did not seek medical attention; also, no laboratory diagnostics or studies were performed. The patient recovered from the event on an unknown date, and she did not provide a causality assessment between the Injection site hypersensitivity and vaccination with PNEUMOVAX 23. The patient also reported an adverse event with losartan potassium (manufacturer unknown) (captured in MARRS # 1801USA003516).; Sender's Comments: US-009507513-1801USA003516:
Sex: F
Vaccine: HEPA
Symptoms: Headache
Clinical narrative: This spontaneous report was received from a patient's aunt and refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided. On 02-JUN-2017, the patient was vaccinated with VAQTA one time, lot # was reported 017982 (dose and route of administration were not provided). On an unknown date, the patient experienced persistent headaches. The outcome of the event was unknown. The causality assessment was not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Decreased immune responsiveness, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 23-JUL-2015 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster.  On or about 22-APR-2016 the patient was treated at a medical center for the onset of severe vesicular rash accompanied by a weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient has been prescribed tramadol, acyclovir and trimethoprim and sulfamethoxazole (BACTRIM) for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.   Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Decreased immune responsiveness, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 09-MAY-2014 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 11-JUN-2016 the patient was treated by a physician for the onset of severe vesicular rash accompanied by a weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient has been prescribed acyclovir (ZOVIRAX) and oxycodone-acetaminophen for management of his painful symptoms. As further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Decreased immune responsiveness, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 19-APR-2012 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-JAN-2015 the patient was treated by a physician for the onset of severe vesicular rash accompanied by a weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient has been prescribed acyclovir (ZOVIRAX) for the management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.     Additional information has been requested.